- Citations, last 5 years
- 199k
- Works, last 5 years
- 15.7k
- h-index
- 1,134
- Scientists listed
- 827
- Grants since 2016
- 1 652
Grants received
2017–2022 · research · R01
Predicting PrEP Uptake and Adherence among Adolescent Girls and Young Women in Sub-Saharan Africa: Leveraging Programmatic and Clinical Trials Data
Ying Qing Chen · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Identification of Novel Mucosal Immune Mechanisms Involved in Protection from HIV-1
Jairam Rao Lingappa · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2019 · fellowship · F32
Elucidating the molecular mechanisms underlying quiescence entry
Marla M Spain · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2021 · research · R01
Understanding Robustness of a Cooperative Microbial Community during Evolution
Wenying Shou · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Disrupting the immune and drug-privileged microenvironment in pancreas cancer
Sunil R Hingorani · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Improving treatment of cardiovascular risk factors in childhood cancer survivors
Eric Jessen Chow · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2019 · fellowship · F32
Hybrid Glycoproteomic and Autoantibody Biomarkers for Lung Cancer Early Detection
Kristin J Lastwika · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
The Gut Microbiota and Graft versus Host Disease (GVHD)
David Neal Fredricks · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2020 · research · R13
Annual Conference For Early Stage HIV/AIDS Vaccine Researchers
James G. Kublin · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Maternal-infant Virome Transmission: the role of HIV and Antiretroviral Therapy
Dara Ann Lehman · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2020 · research · R01
Novel Gene Editing Approaches for Hemoglobinopathies
Hans-Peter Kiem · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2024 · research · R35
Human Papillomavirus and Polyomavirus Associated Malignancies.
Denise A. Galloway · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers
Matthias Stephan · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.
William Mallory Grady · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2020 · research · R13
Annual Conference For Early Stage HIV/AIDS Vaccine Researchers
James G. Kublin · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.
William Mallory Grady · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2020 · research · R01
Comprehensive Colorectal Cancer Risk Prediction to Inform Personalized Screening
Douglas Allen Corley · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Personalized cancer models to discover and develop new therapeutic targets.
Christopher J Kemp · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2020 · career development · K08
Novel targeted therapies for isocitrate dehydrogenase mutantcholangiocarcinoma
Supriya K Saha · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
The Gut Microbiota and Graft versus Host Disease (GVHD)
David Neal Fredricks · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit
Michael Birrer · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · UH3
ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement
Jessica Chubak · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2020 · research · R21
Genetic dissection of circuit modulation for cross-modal plasticity
Jihong Bai · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2020 · research · R01
Novel Gene Editing Approaches for Hemoglobinopathies
Hans-Peter Kiem · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Integrating health informatics in a scalable stepped care self-management program for survivors after hematopoietic cell transplantation
Kevin S Baker · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2019 · contract · N01
TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS
Michael Boeckh · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
(PQ5) Effect of HIV infection on viral and host gene expression and antitumor immunity in Kaposi Sarcoma in Africa
Warren Phipps · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2023 · research · R01
Anti-CD38 targeted alpha emitter radioimmunotherapy to eliminate multiple myeloma
Damian J. Green · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Delineating the mechanisms and clinical utility of mtDNA mutagenesis in cancer
Jason H Bielas · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
Margaret M Madeleine · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Improving treatment of cardiovascular risk factors in childhood cancer survivors
Eric Jessen Chow · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Improving treatment of cardiovascular risk factors in childhood cancer survivors
Eric Jessen Chow · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2020 · cooperative agreement · U01
Disrupting the immune and drug-privileged microenvironment in pancreas cancer
Sunil R Hingorani · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2024 · research · R13
Annual HVTN Translational HIV Early Stage Investigator (ESI) Conference
James G. Kublin · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
An Academic-Industry Partnership to Advance Functional Genomics for Personalized Oncology.
Christopher J Kemp · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Targeting a Novel Hematopoietic Stem Cell Population in Non-Human Primates for Effective and Sustained Gene Therapy
Hans-Peter Kiem · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
Margaret M Madeleine · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R35
Human Papillomavirus and Polyomavirus Associated Malignancies.
Denise A. Galloway · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · award
Contribution of IL-17 Producing Cells to the Pathology of Acute GVHD
Scott Furlan · Fred Hutch Cancer Center · funded by American Cancer Society
2017–2021 · research · R21
Exercise Effects in Men & Women on Colon DNA Methylation
Anne M. Mctiernan · Fred Hutch Cancer Center · funded by National Institutes of Health
